{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:50:05Z","timestamp":1782273005312,"version":"3.54.5"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40272-018-0311-3","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:48:49Z","timestamp":1536540529000},"page":"523-537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux"],"prefix":"10.1007","volume":"20","author":[{"given":"Steven L.","family":"Ciciora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Woodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"311_CR1","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1651-2227.2009.01306.x","volume":"98","author":"B Hegar","year":"2009","unstructured":"Hegar B, Dewanti NR, Kadim M, et al. Natural evolution of regurgitation in healthy infants. Acta Paediatr. 2009;98:1189\u201393.","journal-title":"Acta Paediatr"},{"key":"311_CR2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MPG.0000000000001889","volume":"66","author":"R Rosen","year":"2018","unstructured":"Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66:516\u201354.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR3","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0378-3782(13)70084-7","volume":"8954","author":"L Corvaglia","year":"2013","unstructured":"Corvaglia L, Martini S, Faldella G. Gastro-esophageal reflux: pathogenesis, symptoms, diagnostic and therapeutic management. Early Hum Dev. 2013;8954:S18\u20139.","journal-title":"Early Hum Dev"},{"key":"311_CR4","doi-asserted-by":"crossref","unstructured":"Modlin IM, Sachs G. Developmental anatomy and physiology of the stomach, p 262\u2013268 in Wyllie and Hyams 4th ed. Acid related disease: biology and treatment (book). Schnetztor-Verlag GmbH Koonstanz. 2011. p. 92\u2013110.","DOI":"10.1016\/B978-1-4377-0774-8.10025-9"},{"key":"311_CR5","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/00005176-200311001-00004","volume":"37","author":"JT Boyle","year":"2003","unstructured":"Boyle JT. Acid secretion from birth to adulthood. J Pediatr Gastroenterol Nutr. 2003;37:S12\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40272-013-0012-x","volume":"15","author":"RM Ward","year":"2013","unstructured":"Ward RM, Kearns GL. Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs. 2013;15:119\u201331.","journal-title":"Paediatr Drugs"},{"issue":"1","key":"311_CR7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mpd.2002.120695","volume":"140","author":"RG Heine","year":"2002","unstructured":"Heine RG, Cameron DJ, Chow CW, et al. Esophagitis in distressed infants: poor diagnostic agreement between esophageal pH monitoring and histopathologic findings. J Pediatr. 2002;140(1):4\u20139.","journal-title":"J Pediatr"},{"key":"311_CR8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00431-004-1403-3","volume":"163","author":"Y Vandenplas","year":"2004","unstructured":"Vandenplas Y, Badriul H, Verghote M, et al. Oesophageal pH monitoring and reflux oesophagitis in irritable infants. Eur J Pediatr. 2004;163:300\u20134.","journal-title":"Eur J Pediatr"},{"key":"311_CR9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/bega.2000.0118","volume":"14","author":"RH Holloway","year":"2000","unstructured":"Holloway RH. The anti-reflux barrier and mechanisms of gastroesophageal reflux. Baillieres Clin Gastroenterol. 2000;14:681\u201399.","journal-title":"Baillieres Clin Gastroenterol"},{"key":"311_CR10","doi-asserted-by":"crossref","first-page":"e107954","DOI":"10.1371\/journal.pone.0107954","volume":"9","author":"K-C Chang","year":"2014","unstructured":"Chang K-C, Wu J-F, Hsu W-C, et al. Impacts of endoscopic gastroesophageal flap valve grading on pediatric gastroesophageal reflux disease. PLoS One. 2014;9:e107954.","journal-title":"PLoS One"},{"key":"311_CR11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/gut.51.4.475","volume":"51","author":"TI Omari","year":"2002","unstructured":"Omari TI, Barnett CP, Benninga MA, et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut. 2002;51:475\u20139.","journal-title":"Gut"},{"key":"311_CR12","first-page":"G290","volume":"240","author":"W Dodds","year":"1981","unstructured":"Dodds W, Dent J, Hogan W, et al. Effects of atropine on esophageal motor functions in humans. Am J Physiol. 1981;240:G290\u20136.","journal-title":"Am J Physiol"},{"key":"311_CR13","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1016\/S0002-9343(97)00316-1","volume":"103","author":"P Biancani","year":"1997","unstructured":"Biancani P, Sohn US, Rich HG, et al. Signal transduction pathways in esophageal and lower esophageal sphincter circular muscle. Am J Med. 1997;103:23S\u20138S.","journal-title":"Am J Med"},{"key":"311_CR14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2036.2004.02238.x","volume":"20","author":"DO Castell","year":"2004","unstructured":"Castell DO, Murray JA, Tutuian R, et al. Review article: the pathophysiology of gastro-oesophageal reflux disease\u2014oesophageal manifestations. Aliment Pharmacol Ther. 2004;20:14\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"311_CR15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJM197105202842007","volume":"284","author":"GW Dennish","year":"1971","unstructured":"Dennish GW, Castell DO. Inhibitory effect of smoking on the lower esophageal sphincter. N Eng J Med. 1971;284:1136\u20137.","journal-title":"N Eng J Med"},{"key":"311_CR16","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/BF02071391","volume":"41","author":"SC Kadakia","year":"1996","unstructured":"Kadakia SC, De La Baume HR, Shaffer RT. Effects of transdermal nicotine on lower esophageal sphincter and esophageal motility. Dig Dis Sci. 1996;41:2130\u20134.","journal-title":"Dig Dis Sci"},{"key":"311_CR17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005176-200502000-00024","volume":"40","author":"S Salvatore","year":"2005","unstructured":"Salvatore S, Hauser B, Vandemaele K, et al. Gastroesophageal reflux disease in infants: how much is predictable with questionnaires, pH-metry, endoscopy and histology? J Pediatr Gastroenterol Hepatol Nutr. 2005;40:210\u20135.","journal-title":"J Pediatr Gastroenterol Hepatol Nutr"},{"key":"311_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40272-012-0004-2","volume":"15","author":"SJ Czinn","year":"2013","unstructured":"Czinn SJ, Blanchard S. Gastroesophageal reflux disease in neonates and infants. Pediatr Drugs. 2013;15:19\u201327.","journal-title":"Pediatr Drugs"},{"key":"311_CR19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1542\/peds.88.4.834","volume":"88","author":"Y Vandenplas","year":"1991","unstructured":"Vandenplas Y, Goyvaerts H, Helven R, et al. Gastroesophageal reflux, as measured by 24-h pH monitoring, in 509 healthy infants, screened for risk of sudden infant death syndrome. Pediatrics. 1991;88:834\u201340.","journal-title":"Pediatrics"},{"key":"311_CR20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1442-2050.2012.01384.x","volume":"26","author":"J Richter","year":"2013","unstructured":"Richter J, Pandolfino J, Vela M, et al. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the Esophageal Diagnostic Working Group. Dis Esophagus. 2013;26:755\u201365.","journal-title":"Dis Esophagus"},{"key":"311_CR21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/MPG.0b013e318185dae7","volume":"48","author":"FW Woodley","year":"2009","unstructured":"Woodley FW, Hayes J, Mousa H. Acid gastroesophageal reflux in symptomatic infants is primarily a function of classic 2-phase and pH-only acid reflux types. J Pediatr Gastroenterol Nutr. 2009;48:550\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MPG.0b013e31816f214a","volume":"48","author":"FW Woodley","year":"2009","unstructured":"Woodley FW, Mousa H. pH-only acid reflux events in infants during later phases of the feeding cycle are less acidic and cleared more efficiently than classic 2-phase acid reflux events. J Pediatr Gastroenterol Nutr. 2009;48:41\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MPG.0b013e3181ffde67","volume":"52","author":"H Mousa","year":"2011","unstructured":"Mousa H, Rosen R, Woodley FW, et al. Esophageal impedance monitoring for gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2011;52:129\u201339.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/MPG.0000000000000777","volume":"60","author":"FW Woodley","year":"2015","unstructured":"Woodley FW, Machado R, Di Lorenzo C, Mousa H. Chemical clearance in infants and children with acid reflux in the physiologic range. J Pediatr Gastroenterol Nutr. 2015;60:783\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5223\/pghn.2014.17.1.13","volume":"17","author":"MS Shin","year":"2014","unstructured":"Shin MS. Esophageal pH and combined impedance-pH monitoring in children. Pediatr Gastroenterol Hepatol Nutr. 2014;17:13\u201322.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"311_CR26","first-page":"358","volume":"83","author":"GJ Wiener","year":"1988","unstructured":"Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-h esophageal pH monitoring. Am J Gastroenterol. 1988;83:358\u201361.","journal-title":"Am J Gastroenterol"},{"key":"311_CR27","first-page":"160","volume":"86","author":"R Breumelhof","year":"1991","unstructured":"Breumelhof R, Smout AJPM. The symptom sensitivity index: a valuable additional parameter in 24-h esophageal pH recording. Am J Gastroenterol. 1991;86:160\u20134.","journal-title":"Am J Gastroenterol"},{"key":"311_CR28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/gut.2004.054981","volume":"54","author":"SA Taghavi","year":"2005","unstructured":"Taghavi SA, Ghasedi M, Saberi-Firoozi M, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of a response to high dose omeprazole. Gut. 2005;54:1067\u201371.","journal-title":"Gut"},{"key":"311_CR29","first-page":"1897","volume":"107","author":"WC Orr","year":"1994","unstructured":"Orr WC. The physiology and philosophy of cause and effect. Gastroenterology. 1994;107:1897\u2013901.","journal-title":"Gastroenterology"},{"key":"311_CR30","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-140-7-200404060-00011","volume":"140","author":"ME Numans","year":"2004","unstructured":"Numans ME, Lau J, de Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140:518\u201327.","journal-title":"Ann Intern Med"},{"key":"311_CR31","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1365-2036.2012.05066.x","volume":"35","author":"VM Kushnir","year":"2012","unstructured":"Kushnir VM, Sathyamurthy A, Drapekin J, et al. Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring. Aliment Pharmacol Ther. 2012;35:1080\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"311_CR32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MPG.0000000000000958","volume":"62","author":"R Rosen","year":"2016","unstructured":"Rosen R. Symptom association: an imperfect pairing. J Pediatr Gastroenterol Nutr. 2016;62:517\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/MPG.0000000000000968","volume":"62","author":"A Funderburk","year":"2016","unstructured":"Funderburk A, Nawab U, Abraham A, et al. Temporal association between reflux-like behaviors and gastroesophageal reflux in preterm and term infants. J Pediatr Gastroenterol Nutr. 2016;62:556\u201361.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/gut.2010.233049","volume":"60","author":"R Farre","year":"2011","unstructured":"Farre R, Blobeau K, Clement D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut. 2011;60:885\u201392.","journal-title":"Gut"},{"key":"311_CR35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00535-012-0689-6","volume":"48","author":"C Zhong","year":"2013","unstructured":"Zhong C, Duan L, Wang K, et al. Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease. J Gastroenterol. 2013;48:601\u201310.","journal-title":"J Gastroenterol"},{"key":"311_CR36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MPG.0b013e318214c3cc","volume":"53","author":"CM Loots","year":"2011","unstructured":"Loots CM, von Wijk MP, Smits MJ, et al. Measurement of mucosal conductivity by MII is a potential marker of mucosal integrity restored in infants on acid-suppression therapy. J Pediatr Gastroenterol Nutr. 2011;53:120\u20133.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0016-5085(79)80028-1","volume":"77","author":"WL Palmer","year":"1979","unstructured":"Palmer WL. Bertram Welty sippy (1866\u20131924). Gastroenterology. 1979;77:152\u20135.","journal-title":"Gastroenterology"},{"key":"311_CR38","volume-title":"Acid related diseases: biology and treatment","author":"IM Modulin","year":"2004","unstructured":"Modulin IM, Sachs G. Acid related diseases: biology and treatment. 2nd ed. New York: Lippinscott Williams & Wilkins; 2004.","edition":"2"},{"key":"311_CR39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9610(32)90587-X","volume":"15","author":"A Winkelstein","year":"1932","unstructured":"Winkelstein A. Studies in gastric secretion during the night, with a preliminary note on a new therapy for peptic ulcer. Am J Surg. 1932;15:523\u20134.","journal-title":"Am J Surg"},{"key":"311_CR40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00000441-193305000-00010","volume":"185","author":"A Winkelstein","year":"1933","unstructured":"Winkelstein A. A new therapy of peptic ulcer: continuous alkalinized milk drip into stomach. Am J Med Sci. 1933;185:695\u2013703.","journal-title":"Am J Med Sci"},{"key":"311_CR41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(56)92128-6","volume":"267","author":"R Doll","year":"1956","unstructured":"Doll R, Price AV, Pygott F, et al. Continuous intragastric milk drip in treatment of uncomplicated gastric ulcer. Lancet. 1956;267:70\u20133.","journal-title":"Lancet"},{"key":"311_CR42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.1942.02830450015006","volume":"120","author":"A Winkelstein","year":"1942","unstructured":"Winkelstein A, Cornell A, Hollander F. Intragastric drip therapy for peptic ulcer. JAMA. 1942;120:743\u2013745.","journal-title":"JAMA"},{"key":"311_CR43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1185\/03007999909114087","volume":"15","author":"S Miller","year":"1999","unstructured":"Miller S. Comparison of the efficacy and safety of a new aluminium-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux. Curr Med Res Opin. 1999;15:160\u20138.","journal-title":"Curr Med Res Opin"},{"key":"311_CR44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/adc.2002.024463","volume":"90","author":"R Buono Del","year":"2005","unstructured":"Del Buono R, Wenzl TG, Ball G, et al. Effect of Gaviscon infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance\/pH. Arch Dis Child. 2005;90:460\u20133.","journal-title":"Arch Dis Child"},{"key":"311_CR45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.earlhumdev.2011.05.013","volume":"87","author":"L Corvaglia","year":"2011","unstructured":"Corvaglia L, Spizzichino M, Zama D, et al. Sodium alginate (Gaviscon\u00ae) does not reduce apnoeas related to gastro oesophageal reflux in preterm infants. Early Hum Dev. 2011;87:775\u20138.","journal-title":"Early Hum Dev"},{"key":"311_CR46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2036.2010.04545.x","volume":"33","author":"L Corvaglia","year":"2011","unstructured":"Corvaglia L, Aceti A, Mariani E, et al. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants. Aliment Pharmacol Ther. 2011;33:466\u201370.","journal-title":"Aliment Pharmacol Ther"},{"key":"311_CR47","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MPG.0000000000000521","volume":"60","author":"D Ummarino","year":"2015","unstructured":"Ummarino D, Miele E, Martinelli M, et al. Effect of magnesium alginate plus simethicone on gastroesophageal reflux in infants. J Pediatr Gastroenterol Nutr. 2015;60:230\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR48","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/0091270009338483","volume":"50","author":"B Atasay","year":"2010","unstructured":"Atasay B, Erdeve O, Arsan S, et al. Effect of sodium alginate on acid gastroesophageal reflux disease in preterm infants: a pilot study. J Clin Pharmacol. 2010;50:1267\u201372.","journal-title":"J Clin Pharmacol"},{"key":"311_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-018-0309-x","author":"S Salvatore","year":"2018","unstructured":"Salvatore S, Ripepi A, Huysentruyt K, et al. The effect of alginate in gastroesophageal reflux in infants. Pediatr Drugs. 2018. https:\/\/doi.org\/10.1007\/s40272-018-0309-x","journal-title":"Pediatr Drugs"},{"key":"311_CR50","first-page":"40","volume":"55","author":"I Loore De","year":"1979","unstructured":"De Loore I, Van Ravensteyn H, Ameryckx L. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. Postgrad Med J. 1979;55:40\u20132.","journal-title":"Postgrad Med J"},{"key":"311_CR51","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365529409094839","volume":"29","author":"A Carroccio","year":"1994","unstructured":"Carroccio A, Iacono G, Montalto G, et al. Domperidone plus magnesium hydroxide and aluminum hydroxide: a valid therapy in children with gastroesophageal reflux. A double-blind randomized study versus placebo. Scand J Gastroenterol. 1994;29:300\u20134.","journal-title":"Scand J Gastroenterol"},{"key":"311_CR52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-3476(89)80351-8","volume":"115","author":"V Tolia","year":"1989","unstructured":"Tolia V, Calhoun J, Kuhns L, et al. Randomized, prospective double blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. J Pediatr. 1989;115:141\u20135.","journal-title":"J Pediatr"},{"key":"311_CR53","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jpeds.2005.12.026","volume":"148","author":"P Nuntnarumit","year":"2006","unstructured":"Nuntnarumit P, Kiatchoosakun P, Tantiprapa W, et al. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants. J Pediatr. 2006;148:600\u20135.","journal-title":"J Pediatr"},{"key":"311_CR54","doi-asserted-by":"crossref","first-page":"F177","DOI":"10.1136\/fn.84.3.F177","volume":"84","author":"PC Ng","year":"2001","unstructured":"Ng PC, So KW, Fung KS, et al. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2001;84:F177\u201382.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"311_CR55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1440-1754.1997.tb01018.x","volume":"33","author":"PC Ng","year":"1997","unstructured":"Ng PC, Fok TF, Lee CH, Wong W, Cheung KL. Erythromycin treatment for gastrointestinal dysmotility in preterm infants. J Paediatr Child Health. 1997;33:148\u201350.","journal-title":"J Paediatr Child Health"},{"key":"311_CR56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0002-9343(89)90162-9","volume":"86","author":"F Arg\u00fcelles-Martin","year":"1989","unstructured":"Arg\u00fcelles-Martin F, Gonzalez-Fernandez F, Gentles MG. Sucralfate versus cimetidine in the treatment of reflux esophagitis in children. Am J Med. 1989;86:73\u20136.","journal-title":"Am J Med"},{"key":"311_CR57","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/MPG.0b013e3182a2747b","volume":"57","author":"NB Vadlamudi","year":"2013","unstructured":"Vadlamudi NB, Hitch MC, Dimmitt RA, et al. Baclofen for the treatment of pediatric GERD. J Pediatr Gastroenterol Nutr. 2013;57:808\u201312.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR58","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jpeds.2008.09.054","volume":"154","author":"SR Orenstein","year":"2009","unstructured":"Orenstein SR, Hassall E, Furmaga-Jablonska W, et al. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154:514\u201320.","journal-title":"J Pediatr"},{"key":"311_CR59","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00003246-199702000-00025","volume":"25","author":"AL Kuusela","year":"1997","unstructured":"Kuusela AL, Ruuska T, Karikoski R, et al. A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients. Crit Care Med. 1997;25:346\u201351.","journal-title":"Crit Care Med"},{"key":"311_CR60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pedneo.2013.01.011","volume":"54","author":"A Bilali","year":"2013","unstructured":"Bilali A, Galanis P, Bartsocas C, et al. H2RA-blocker therapy and incidence of necrotizing enterocolitis in preterm infants: a case-control study. Pediatr Neonatol. 2013;54:141\u20132.","journal-title":"Pediatr Neonatol."},{"key":"311_CR61","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1542\/peds.2005-1543","volume":"117","author":"R Guillet","year":"2006","unstructured":"Guillet R, Stoll BJ, Cotten CM, et al. National Institute of Child Health and Human Development Neonatal Research Network. Association of H2RA-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2006;117:e137\u201342.","journal-title":"Pediatrics"},{"key":"311_CR62","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1542\/peds.2011-0796","volume":"129","author":"G Terrin","year":"2012","unstructured":"Terrin G, Passariello A, De Curtis M, et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics. 2012;129:e40\u20135.","journal-title":"Pediatrics"},{"key":"311_CR63","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12879-017-2482-x","volume":"17","author":"RNS Santana","year":"2017","unstructured":"Santana RNS, Santos VS, Ribeiro-J\u00fanior RF, et al. Use of ranitidine is associated with infections in newborns hospitalized in a neonatal intensive care unit: a cohort study. BMC Infect Dis. 2017;17:375.","journal-title":"BMC Infect Dis"},{"key":"311_CR64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00005176-199010000-00006","volume":"11","author":"V Carrion","year":"1990","unstructured":"Carrion V, Egan EA. Prevention of neonatal necrotizing enterocolitis. J Pediatr Gastroenterol Nutr. 1990;11:317\u201323.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR65","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1542\/peds.65.2.301","volume":"65","author":"Y Chhattriwalla","year":"1980","unstructured":"Chhattriwalla Y, Colon AR, Scanlon JW. The use of cimetidine in the newborn. Pediatrics. 1980;65:301\u20132.","journal-title":"Pediatrics"},{"key":"311_CR66","first-page":"465","volume":"27","author":"AK Agarwal","year":"1990","unstructured":"Agarwal AK, Saili A, Pandey KK, et al. Role of cimetidine in prevention and treatment of stress induced gastric bleeding in neonates. Indian Pediatr. 1990;27:465\u20139.","journal-title":"Indian Pediatr"},{"key":"311_CR67","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clinthera.2005.04.008","volume":"27","author":"SR Orenstein","year":"2005","unstructured":"Orenstein SR, Gremse DA, Pantaleon CD, et al. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children. Clin Ther. 2005;27:472\u201383.","journal-title":"Clin Ther"},{"issue":"1089","key":"311_CR68","first-page":"1095","volume":"38","author":"LP James","year":"1998","unstructured":"James LP, Marotti T, Stowe CD, et al. Pharmacokinetics and pharmacodynamics of famotidine in infants. J Clin Pharmacol. 1998;38(1089):1095 (Erratum. In: J Clin Pharmacol 2000;40:1298).","journal-title":"J Clin Pharmacol"},{"key":"311_CR69","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/00003088-200544040-00004","volume":"44","author":"LA Wenning","year":"2005","unstructured":"Wenning LA, Murphy MG, James LP, et al. Pharmacokinetics of famotidine in infants. Clin Pharmacokinet. 2005;44:395\u2013406.","journal-title":"Clin Pharmacokinet"},{"key":"311_CR70","first-page":"593","volume":"10","author":"YY Wu","year":"2008","unstructured":"Wu YY. Efficacy and safety of famotidine for the treatment of stress ulcers in neonates. Zhongguo Dang Dai Er Ke Za Zhi. 2008;10:593\u20135.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi."},{"key":"311_CR71","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1365-2036.2003.01559.x","volume":"17","author":"SR Orenstein","year":"2003","unstructured":"Orenstein SR, Shalaby TM, Devandry SN, et al. Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial. Aliment Pharmacol Ther. 2003;17:1097\u2013107.","journal-title":"Aliment Pharmacol Ther"},{"key":"311_CR72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/S0022-3476(03)00207-5","volume":"143","author":"DJ Moore","year":"2003","unstructured":"Moore DJ, Tao BS, Lines DR, Hirte C, Heddle ML, Davidson GP. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr. 2003;143:219\u201323.","journal-title":"J Pediatr"},{"key":"311_CR73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.mpg.0000252190.97545.07","volume":"44","author":"TI Omari","year":"2007","unstructured":"Omari TI, Haslam RR, Lundborg P, Davidson GP. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux. J Pediatr Gastroenterol Nutr. 2007;44:41\u20134.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR74","first-page":"111","volume":"41","author":"M Orsi","year":"2011","unstructured":"Orsi M, Donato G, Busoni V, Naisberg G, Caruso N. Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study. Acta Gastroenterol Latinoam. 2011;41:111\u20138.","journal-title":"Acta Gastroenterol Latinoam"},{"key":"311_CR75","doi-asserted-by":"crossref","first-page":"e0166207","DOI":"10.1371\/journal.pone.0166207","volume":"11","author":"F Kaguelidou","year":"2016","unstructured":"Kaguelidou F, Alberti C, Biran V, et al. Dose-finding study of omeprazole on gastric pH in neonates with gastro-esophageal acid reflux using a Bayesian sequential approach. PLoS One. 2016;11:e0166207.","journal-title":"PLoS One"},{"key":"311_CR76","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPG.0b013e31815667d7","volume":"46","author":"V Khoshoo","year":"2008","unstructured":"Khoshoo V, Dhume P. Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2008;46:352\u20134.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR77","first-page":"283","volume":"19","author":"M Illueca","year":"2014","unstructured":"Illueca M, Alemayehu B, Shoetan N, et al. Proton pump inhibitor prescribing patterns in newborns and infants. J Pediatr Pharmacol Ther. 2014;19:283\u20137.","journal-title":"J Pediatr Pharmacol Ther."},{"key":"311_CR78","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpeds.2013.05.007","volume":"163","author":"G Davidson","year":"2013","unstructured":"Davidson G, Wenzl TG, Thomson M, et al. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients. J Pediatr. 2013;163:692\u20138.","journal-title":"J Pediatr."},{"key":"311_CR79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MPG.0b013e318272af3b","volume":"55","author":"H Winter","year":"2012","unstructured":"Winter H, Gunasekaran T, Tolia V, et al. Esomeprazole for the treatment of GERD in infants ages 1\u201311\u00a0months. J Pediatr Gastroenterol Nutr. 2012;55:14\u201320.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl 1","key":"311_CR80","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/01.mpg.0000469415.50085.f7","volume":"60","author":"T Omari","year":"2015","unstructured":"Omari T, Davidson G, Bondarov P, et al. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1\u201324\u00a0months old with symptoms of gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2015;60(Suppl 1):S2\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"311_CR81","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MPG.0b013e31812e012f","volume":"45","author":"T Omari","year":"2007","unstructured":"Omari T, Davidson G, Bondarov P, et al. Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1\u201324\u00a0months old with symptoms of gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2007;45(5):530\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR82","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MPG.0000000000000195","volume":"58","author":"S Hussain","year":"2014","unstructured":"Hussain S, Kierkus J, Hu P, et al. Safety and efficacy of delayed release rabeprazole in 1- to 11-month-old infants with symptomatic GERD. J Pediatr Gastroenterol Nutr. 2014;58:226\u201336.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR83","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10620-010-1321-3","volume":"56","author":"J Kierkus","year":"2011","unstructured":"Kierkus J, Furmaga-Jablonska W, Sullivan JE, et al. Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11\u00a0months with a clinical diagnosis of gastroesophageal reflux disease. Dig Dis Sci. 2011;56:425\u201334.","journal-title":"Dig Dis Sci"},{"key":"311_CR84","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MPG.0b013e3181c2bf41","volume":"50","author":"H Winter","year":"2010","unstructured":"Winter H, Kum-Nji P, Mahomedy SH, et al. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1\u201311\u00a0months old with symptomatic GERD. J Pediatr Gastroenterol Nutr. 2010;50:609\u201318.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR85","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1542\/peds.102.6.e67","volume":"102","author":"SP Nelson","year":"1998","unstructured":"Nelson SP, Chen EH, Syniar GM, et al. One-year follow-up of symptoms of gastroesophageal reflux during infancy. Pediatric Practice Research Group. Pediatrics. 1998;102:E67.","journal-title":"Pediatrics."},{"key":"311_CR86","first-page":"CD003211","volume":"12","author":"TC Kwok","year":"2017","unstructured":"Kwok TC, Ojha S, Dorling J. Feed thickener for infants up to 6\u00a0months of age with gastro-oesophageal reflux. Cochrane Database Syst Rev. 2017;12:CD003211.","journal-title":"Cochrane Database Syst Rev."},{"key":"311_CR87","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jamapediatrics.2016.0120","volume":"170","author":"MR Karagas","year":"2016","unstructured":"Karagas MR, Punshon T, Sayarath V, et al. Association of rice and rice-product consumption with arsenic exposure early in life. JAMA Pediatr. 2016;170:609\u201316.","journal-title":"JAMA Pediatr."},{"key":"311_CR88","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jpeds.2012.03.054","volume":"161","author":"J Beal","year":"2012","unstructured":"Beal J, Silverman B, Bellant J, et al. Late onset necrotizing enterocolitis in infants following use of a xanthan gum-containing thickening agent. J Pediatr. 2012;161:354\u20136.","journal-title":"J Pediatr"},{"key":"311_CR89","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/adc.2006.110999","volume":"92","author":"Y Vandenplas","year":"2007","unstructured":"Vandenplas Y, Koletzko S, Isolauri E, et al. Guidelines for the diagnosis and management of cow\u2019s milk protein allergy in infants. Arch Dis Child. 2007;92:902\u20138 (Review. Erratum in: Arch Dis Child. 2008; 93: 93. Arch Dis Child. 2007; 92:following 908).","journal-title":"Arch Dis Child"},{"key":"311_CR90","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamapediatrics.2013.4367","volume":"168","author":"F Indrio","year":"2014","unstructured":"Indrio F, Di Mauro A, Riezzo G, et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: a randomized clinical trial. JAMA Pediatr. 2014;168:228\u201333.","journal-title":"JAMA Pediatr."},{"key":"311_CR91","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/adc.76.3.254","volume":"76","author":"JM Tobin","year":"1997","unstructured":"Tobin JM, McCloud P, Cameron DJ. Posture and gastro-oesophageal reflux: a case for left lateral positioning. Arch Dis Child. 1997;76:254\u20138.","journal-title":"Arch Dis Child"},{"key":"311_CR92","doi-asserted-by":"crossref","first-page":"F201","DOI":"10.1136\/fn.81.3.F201","volume":"81","author":"AK Ewer","year":"1999","unstructured":"Ewer AK, James ME, Tobin JM. Prone and left lateral positioning reduce gastro-oesophageal reflux in pre-term infants. Arch Dis Child Fetal Neonatal Ed. 1999;81:F201\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"311_CR93","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jpeds.2004.05.026","volume":"145","author":"T Omari","year":"2004","unstructured":"Omari T, Rommel N, Staunton E, et al. Paradoxical impact of body positioning on gastroesophageal reflux and gastric emptying in the premature neonate. J Pediatr. 2004;145:194\u2013200.","journal-title":"J Pediatr"},{"key":"311_CR94","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jpeds.2007.06.015","volume":"151","author":"MP Wijk van","year":"2007","unstructured":"van Wijk MP, Benninga MA, Dent J, et al. Effect of body position changes on triggering of postprandial gastroesophageal reflux and gastric emptying in the premature neonate. J Pediatr. 2007;151:585\u201390.","journal-title":"J Pediatr"},{"key":"311_CR95","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpeds.2007.06.014","volume":"151","author":"L Corvaglia","year":"2007","unstructured":"Corvaglia L, Rotatori R, Ferlini M, et al. The effect of body positioning on gastroesophageal reflux in premature infants: evaluation by combined impedance and pH monitoring. J Pediatr. 2007;151:591\u20136.","journal-title":"J Pediatr"},{"key":"311_CR96","first-page":"193","volume":"60","author":"T Omari","year":"2008","unstructured":"Omari T. Gastroesophageal reflux in infants: can a simple left side positioning strategy help this diagnostic and therapeutic conundrum? Minerva Pediatr. 2008;60:193\u2013200.","journal-title":"Minerva Pediatr"},{"key":"311_CR97","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MPG.0000000000000395","volume":"59","author":"C Loots","year":"2014","unstructured":"Loots C, Kritas S, van Wijk M, et al. Body positioning and medical therapy for infantile gastroesophageal reflux symptoms. J Pediatr Gastroenterol Nutr. 2014;59:237\u201343.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR98","doi-asserted-by":"crossref","first-page":"e20162938","DOI":"10.1542\/peds.2016-2938","volume":"138","author":"Task Force on Sudden Infant Death Syndrome","year":"2016","unstructured":"Task Force on Sudden Infant Death Syndrome. SIDS and other sleep-related infant deaths: updated 2016 recommendations for a safe infant sleeping environment. Pediatrics. 2016;138:e20162938.","journal-title":"Pediatrics"},{"key":"311_CR99","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.3109\/17477166.2010.491118","volume":"6","author":"C Koebnick","year":"2011","unstructured":"Koebnick C, Getahun D, Ning Smith, et al. Extreme childhood obesity is associated with increased risk for gastroesophageal reflux disease in a large population-based study. Int J Pediatr Obes. 2011;6:e257\u201363.","journal-title":"Int J Pediatr Obes"},{"key":"311_CR100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bcp.12619","volume":"80","author":"S Cohen","year":"2015","unstructured":"Cohen S, Bueno de Mesquita M, Mimouni FB. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10\u00a0years literature review. Br J Clin Pharmacol. 2015;80:200\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"311_CR101","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10620-007-9880-7","volume":"53","author":"V Tolia","year":"2008","unstructured":"Tolia V, Boyer K. Long-term proton pump inhibitor use in children: a retrospective review of safety. Dig Dis Sci. 2008;53:385\u201393.","journal-title":"Dig Dis Sci"},{"key":"311_CR102","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MPG.0b013e31829b6914","volume":"57","author":"W Treem","year":"2013","unstructured":"Treem W, Hu P, Sloan S. Normal and proton pump inhibitor-mediated gastrin levels in infants 1\u201311\u00a0months old. J Pediatr Gastroenterol Nutr. 2013;57:520\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR103","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2036.2009.04229.x","volume":"31","author":"R Turco","year":"2010","unstructured":"Turco R, Martinelli M, Miele E, et al. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther. 2010;31:754\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"311_CR104","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpeds.2017.03.032","volume":"186","author":"DJ Adams","year":"2017","unstructured":"Adams DJ, Eberly MD, Rajnik M, et al. Risk factors for community-associated Clostridium difficile infection in children. J Pediatr. 2017;186:105\u20139.","journal-title":"J Pediatr"},{"key":"311_CR105","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/cid\/civ432","volume":"61","author":"DE Freedberg","year":"2015","unstructured":"Freedberg DE, Lamous\u00e9-Smith ES, Lightdale JR, et al. Use of acid suppression medication is associated with risk for C. difficile infection in infants and children: a population-based study. Clin Infect Dis. 2015;61:912\u20137.","journal-title":"Clin Infect Dis"},{"key":"311_CR106","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MPG.0000000000000790","volume":"61","author":"J Jimenez","year":"2015","unstructured":"Jimenez J, Drees M, Loveridge-Lenza B, et al. Exposure to gastric acid-suppression therapy is associated with health care- and community-associated Clostridium difficile infection in children. J Pediatr Gastroenterol Nutr. 2015;61:208\u201311.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR107","unstructured":"FDA. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm290510.htm . Accessed 29 Mar 2018."},{"key":"311_CR108","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10654-016-0136-8","volume":"31","author":"RJ Hassing","year":"2016","unstructured":"Hassing RJ, Verbon A, de Visser H, et al. Proton pump inhibitors and gastroenteritis. Eur J Epidemiol. 2016;31:1057\u201363.","journal-title":"Eur J Epidemiol"},{"key":"311_CR109","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.3748\/wjg.v21.i22.6817","volume":"21","author":"S Fujimori","year":"2015","unstructured":"Fujimori S. What are the effects of proton pump inhibitors on the small intestine? World J Gastroenterol. 2015;21:6817\u20139.","journal-title":"World J Gastroenterol"},{"key":"311_CR110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.dld.2013.08.128","volume":"46","author":"B Lebwohl","year":"2014","unstructured":"Lebwohl B, Spechler SJ, Wang TC, et al. Use of proton pump inhibitors and subsequent risk of celiac disease. Dig Liver Dis. 2014;46:36\u201340.","journal-title":"Dig Liver Dis."},{"key":"311_CR111","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/gastro\/gou054","volume":"3","author":"JW Toh","year":"2015","unstructured":"Toh JW, Ong E, Wilson R. Hypomagnesaemia associated with long-term use of proton pump inhibitors. Gastroenterol Rep (Oxf). 2015;3:243\u201353.","journal-title":"Gastroenterol Rep (Oxf)."},{"key":"311_CR112","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ajg.2015.119","volume":"110","author":"GM Masclee","year":"2015","unstructured":"Masclee GM, Coloma PM, Kuipers EJ, et al. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol. 2015;110:749\u201359.","journal-title":"Am J Gastroenterol"},{"key":"311_CR113","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11894-012-0290-4","volume":"14","author":"YX Yang","year":"2012","unstructured":"Yang YX. Chronic proton pump inhibitor therapy and calcium metabolism. Curr Gastroenterol Rep. 2012;14:473\u20139.","journal-title":"Curr Gastroenterol Rep"},{"key":"311_CR114","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ekir.2017.01.005","volume":"2","author":"S Toth-Manikowski","year":"2017","unstructured":"Toth-Manikowski S, Grams ME. Proton pump inhibitors and kidney disease\u2014GI upset for the nephrologist? Kidney Int Rep. 2017;2:297\u2013301.","journal-title":"Kidney Int Rep."},{"key":"311_CR115","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.32.8.821","volume":"32","author":"XQ Li","year":"2004","unstructured":"Li XQ, Andersson TB, Ahlstr\u00f6m M, et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos. 2004;32:821\u20137.","journal-title":"Drug Metab Dispos"},{"key":"311_CR116","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1124\/dmd.112.045575","volume":"40","author":"T Zvyaga","year":"2012","unstructured":"Zvyaga T, Chang SY, Chen C, et al. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. Drug Metab Dispos. 2012;40:1698\u2013711.","journal-title":"Drug Metab Dispos"},{"key":"311_CR117","first-page":"203","volume":"69","author":"UA Meyer","year":"1996","unstructured":"Meyer UA. Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions. Yale J Biol Med. 1996;69:203\u20139.","journal-title":"Yale J Biol Med."},{"key":"311_CR118","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MPG.0b013e31812e0149","volume":"45","author":"JJ Barron","year":"2007","unstructured":"Barron JJ, Tan H, Spalding J, et al. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45:421\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"63\u201370","key":"311_CR119","first-page":"e3","volume":"174","author":"JL Slaughter","year":"2016","unstructured":"Slaughter JL, Stenger MR, Reagan PB, et al. Neonatal histamine-2 receptor antagonist and proton pump inhibitor treatment at United States children\u2019s hospitals. J Pediatr. 2016;174(63\u201370):e3.","journal-title":"J Pediatr"},{"key":"311_CR120","doi-asserted-by":"crossref","first-page":"e20161977","DOI":"10.1542\/peds.2016-1977","volume":"138","author":"JA D\u2019Agostino","year":"2016","unstructured":"D\u2019Agostino JA, Passarella M, Martin AE, et al. Use of gastroesophageal reflux medications in premature infants after NICU discharge. Pediatrics. 2016;138:e20161977.","journal-title":"Pediatrics"},{"key":"311_CR121","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/MPG.0000000000001596","volume":"65","author":"ML Blank","year":"2017","unstructured":"Blank ML, Parkin L. National study of off-label proton pump inhibitor use among New Zealand infants in the first year of life (2005\u20132012). J Pediatr Gastroenterol Nutr. 2017;65:179\u201384.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"311_CR122","first-page":"219","volume":"88","author":"C Erenoglu","year":"2003","unstructured":"Erenoglu C, Miller A, Schirmer B. Laproscopic troupet versus nissen fundoplication for treatment of gastroesophageal reflux disease. Int Surg. 2003;88:219\u201325.","journal-title":"Int Surg"},{"key":"311_CR123","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5223\/pghn.2014.17.2.93","volume":"17","author":"BG Yoo","year":"2014","unstructured":"Yoo BG, Yang HK, Lee YJ, et al. Fundoplication in neonates and infants with primary gastroesophageal reflux. Pediatr Gastroenterol Hepatol Nutr. 2014;17:93\u20137.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"311_CR124","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1440-1754.1991.tb00402.x","volume":"27","author":"RN Justo","year":"1991","unstructured":"Justo RN, Gray PH. Fundoplication in preterm infants with gastro-oesophageal reflux. J Pediatr Child Health. 1991;27:250\u20134.","journal-title":"J Pediatr Child Health"},{"key":"311_CR125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0022-3468(94)90739-0","volume":"29","author":"NL Kazerooni","year":"1991","unstructured":"Kazerooni NL, VanCamp J, Hirschi RB, et al. Fundoplication in 160 children under 2\u00a0years of age. J Pediatr Surg. 1991;29:677\u201381.","journal-title":"J Pediatr Surg"},{"key":"311_CR126","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-3468(99)90194-X","volume":"34","author":"R Kubiak","year":"1999","unstructured":"Kubiak R, Spitz L, Kiely EM, et al. Effectiveness of fundoplication in early infancy. J Pediatr Surg. 1999;34:295\u20139.","journal-title":"J Pediatr Surg"},{"key":"311_CR127","doi-asserted-by":"crossref","first-page":"b4411","DOI":"10.1136\/bmj.b4411","volume":"339","author":"R Srivastava","year":"2009","unstructured":"Srivastava R, Berry JG, Hall M, et al. Reflux-related hospital admissions after fundoplication in children with neurological impairment: retrospective cohort study. BMJ. 2009;339:b4411.","journal-title":"BMJ"},{"key":"311_CR128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/863527","volume":"2013","author":"HT Jackson","year":"2013","unstructured":"Jackson HT, Kane TD. Surgical management of pediatric gastroesophageal reflux disease. Gastroenterol Res Pract. 2013;2013:1\u20138.","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"311_CR129","first-page":"07","volume":"37","author":"PW Wales","year":"2002","unstructured":"Wales PW, Diamond IR, Dutta S, et al. Fundoplication and gastrostomy versus image-guided gastrojejunal tube for enteral feeding in neurologically impaired children with gastroesophageal reflux. J Pediatr Surg. 2002;37(4):07\u2013412.","journal-title":"J Pediatr Surg"},{"key":"311_CR130","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jpedsurg.2009.06.020","volume":"44","author":"J Boubnova","year":"2009","unstructured":"Boubnova J, Hery G, Ughetto F, et al. Laparoscopic total esophagastric dissociation. J Pediatr Surg. 2009;44:e1\u20133.","journal-title":"J Pediatr Surg."},{"key":"311_CR131","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5056\/jnm18015","volume":"24","author":"FW Woodley","year":"2018","unstructured":"Woodley FW. A positive reflux-symptom association is not marked when the onset of the reflux episode does not occur within the pre-symptom time window. J Neurogastroenterol Motil. 2018;24:324\u20135.","journal-title":"J Neurogastroenterol Motil"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-018-0311-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0311-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0311-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T03:50:31Z","timestamp":1720583431000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-018-0311-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":131,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1007\/s40272-018-0311-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"10 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No external funding was used in the writing of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Drs. Ciciora and Woodley have no conflicts of interest to report related to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}